RA CAPITAL MANAGEMENT, L.P. - 01 Jul 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
ETNB
Transactions as of
01 Jul 2022
Net transactions value
+$10,002,812
Form type
4
Filing time
06 Jul 2022, 17:27:14 UTC
Previous filing
23 Jun 2022
Next filing
28 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Purchase $9,999,995 +2,816,900 +57% $3.55 7,782,669 01 Jul 2022 See Footnotes F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Warrants (Right to Buy) Purchase $2,817 +2,816,900 $0.001000* 1,408,450 01 Jul 2022 Common Stock 1,408,450 $5.32 See footnotes F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund") and the RA Capital Nexus Fund L.P. (the "Nexus Fund").
F2 These Securities are held solely by the Fund.
F3 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Remarks:

Mr. Derek DiRocco, a Partner of the Adviser, serves on the Issuer's board of directors.